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The chb operon constitutes the genes essential for utilization of chitooligosaccharides in 
Escherichia coli and related species. The six genes of the operon code for a transcriptional 
regulator (ChbR) of the operon, a permease (ChbBCA), a monodeacetylase (ChbG), and a 
phospho-β-glucosidase (ChbF). In the absence of the substrate, the operon is maintained in a 
transcriptionally repressed state, while presence of the substrate leads to transcriptional 
activation. Regulation of the chb operon is brought about by the concerted action of three 
proteins, the negative regulator NagC coded by the nag operon, the dual function regulator 
ChbR coded by the chb operon and the universal regulatory protein CRP. Mutations that lead 
to alterations in the regulation of the operon can facilitate utilization of cellobiose, in addition 
to chitooligosaccharides by E. coli.  
The studies presented in Chapter II were aimed at understanding the evolution of cellobiose 
utilization in Shigella sonnei, which is phylogenetically very close to E. coli. Cel
+
 mutants 
were isolated from a Cel
-
 wild type S. sonnei strain. Interestingly, Cel
+
 mutants arose 
relatively faster on MacConkey cellobiose agar from the S. sonnei wild type strain compared 
to E. coli. Similar to E. coli, the Cel
+
 phenotype in S. sonnei mutants was linked to the chb 
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operon. Deletion of the phospho-β-glucosidase gene, chbF also resulted in loss of the Cel+ 
phenotype, indicating that ChbF is responsible for hydrolysis of cellobiose in these mutants. 
Previous work from the lab has shown that acquisition of two classes of mutations is 
necessary and sufficient to give rise to Cel
+
 mutants in E. coli. The first class of mutations 
either within the nagC locus or at the NagC binding site within the chb promoter, lead to 
NagC derepression. The second class consisting of gain-of-function mutations in chbR enable 
the recognition of cellobiose as an inducer by ChbR and subsequent activation of the operon. 
However, in S. sonnei a single mutational event of an IS element insertion resulted in 
acquisition of this phenotype. Depending on the type and location of the insertion, the 
mutants were grouped as Type I, and Type II. In Type I mutants an 1S600 insertion between 
the inherent -10 and -35 elements within the chb promoter leads to ChbR-independent 
constitutive activation of the operon, while in Type II mutants, an IS2/600 insertion at -113/-
114, leads to ChbR-dependent, cellobiose-inducible expression of the operon. The results 
presented also indicate that in addition to relieving NagC mediated repression, the insertion in 
Type II mutants also leads to increase in basal transcription from the chb promoter. 
Constitutive expression of the chb operon also results in utilization of the aromatic β-
glucosides salicin and arbutin, in addition to cellobiose in Type I mutants, which indicates the 
promiscuous nature of permease and hydrolysis enzyme of the chb operon.  
This part of the thesis essentially demonstrates the different trajectories taken for the 
evolution of new metabolic function under conditions of nutrient stress by two closely related 
species. It emphasizes the significance of the strain background, namely the diversity of 
transposable elements in the acquisition of the novel function. 
The second part of this research investigation, detailed in Chapter III deals with experiments 
to characterize the eukaryotic orthologs of the last gene of the chb operon. The chbG gene of 
E. coli codes for a monodeacetylase of chitooligosaccharides like chitobiose and chitotriose. 
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The protein belongs to a highly conserved, but less explored family of proteins called YdjC, 
whose orthologs are present in many prokaryotes and eukaryotes including mammals. The 
human YDJC locus located on chromosome 22 is linked to a variety of inflammatory diseases 
and the transcript levels are relatively high in stem cells and a few cancer cells. In silico 
analysis suggested that the mammalian YdjC orthologs possess sequence and structural 
similarity with the prokaryotic counterpart. The full length mouse YdjC ortholog, which is 
85% identical to the human ortholog was cloned into a bacterial vector and expressed in a 
chbG deletion strain of E. coli. The mouse YdjC ortholog could neither promote growth of 
the strain on chitobiose nor induce transcription from the chb promoter. The purified mouse 
YdjC ortholog could not deacetylate chitobiose in vitro as well, suggesting that the mouse 
ortholog failed to complement the function of the E. coli counterpart, ChbG under the 
conditions tested in this study. In order to characterize the mammalian YdjC orthologs more 
elaborately, further experimentation was performed in mammalian cell lines. The results 
indicate that YdjC is expressed in mammalian cell lines of different tissue origin and the 
expression was seen throughout the cell. Overexpression of mouse Ydjc in a few mammalian 
cells also resulted in increased proliferation and migration, indicating a direct or indirect role 
of this protein in cell growth/proliferation. The mammalian orthologs of ChbG therefore 
appear to have related but distinct activities and substrates compared to the bacterial 
counterpart, that need to be elucidated further.  
